This Phase 2 trial opened for recruitment 12th July 2022 ..... almost exactly a year ago.
The USA website referred to in this presentation indicates 20 participants needed and completion expected last May.
Googling gives the info that in Australia there are approx 500 known individuals and probably another 1,000 yet to be diagnosed
.... so with 500 potential participants why is this trial taking so long? Does anyone here know?
.
Ann: Neuren commences Phase 2 trial of NNZ-2591 in Angelman, page-19
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.39 |
Change
-0.470(2.37%) |
Mkt cap ! $2.478B | |||
| Open | High | Low | Value | Volume |
| $19.70 | $19.77 | $19.28 | $10.38M | 534.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 2680 | $19.35 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.41 | 362 | 1 |
View Market Depth
| Last trade - 16.10pm 30/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |